Sarah Kim

Sarah Kim is a senior at the University of Washington majoring in biochemistry. She is characterizing how resistance evolves at the dihydrofolate reductase-thymidylate synthase (DHFR-TS) locus, which encodes a key, validated drug target in malaria chemotherapy. When not in lab or studying, she spends her time dabbling in songwriting, cooking for friends, and spending time with her husband and dog.

Email: email